Columbus Circle Investors’s Insys Therapeutics, Inc. INSY Stock Holding History

Columbus Circle Investors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,949	Closed	-$357K	–	325
2015 Q2	$357K	Sell	9,949 -47,553	-83%	-$1.48M	﹤0.01%	267
2015 Q1	$1.67M	Sell	57,502 -11,730	-17%	-$310K	0.01%	253
2014 Q4	$1.46M	Buy	+69,232	New	+$1.37M	0.01%	251

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Columbus Circle Investors's INSY Position: Q3 2015 in Review

Columbus Circle Investors sold out of Insys Therapeutics, Inc. (INSY) in Q3 2015, closing a stake of 9,949 shares — an estimated $357K sold.

Columbus Circle Investors first reported a position in INSY in Q4 2014 and held it in 3 quarters. The position peaked at $1.67M in Q1 2015. 145 funds tracked by Wall St. Rank hold INSY as of Q3 2015.

Columbus Circle Investors reported no remaining Insys Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Columbus Circle Investors sold 9,949 Insys Therapeutics, Inc. shares in Q3 2015, an estimated $357K.
Columbus Circle Investors first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 3 quarters.
Columbus Circle Investors's Insys Therapeutics, Inc. position peaked at $1.67M in Q1 2015.
145 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2015.

Based on Columbus Circle Investors's 13F filing for Q3 2015, filed 2 Nov 2015.